327 related articles for article (PubMed ID: 32788639)
1. The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis.
Sun Z; Jiang Q; Li J; Guo J
Signal Transduct Target Ther; 2020 Aug; 5(1):150. PubMed ID: 32788639
[TBL] [Abstract][Full Text] [Related]
2. The diverse oncogenic and tumor suppressor roles of salt-inducible kinase (SIK) in cancer.
Du WQ; Zheng JN; Pei DS
Expert Opin Ther Targets; 2016; 20(4):477-85. PubMed ID: 26549013
[TBL] [Abstract][Full Text] [Related]
3. The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.
Hollstein PE; Eichner LJ; Brun SN; Kamireddy A; Svensson RU; Vera LI; Ross DS; Rymoff TJ; Hutchins A; Galvez HM; Williams AE; Shokhirev MN; Screaton RA; Berdeaux R; Shaw RJ
Cancer Discov; 2019 Nov; 9(11):1606-1627. PubMed ID: 31350328
[TBL] [Abstract][Full Text] [Related]
4. The Salt-Inducible Kinases: Emerging Metabolic Regulators.
Sakamoto K; Bultot L; Göransson O
Trends Endocrinol Metab; 2018 Dec; 29(12):827-840. PubMed ID: 30385008
[TBL] [Abstract][Full Text] [Related]
5. Nuts and bolts of the salt-inducible kinases (SIKs).
Darling NJ; Cohen P
Biochem J; 2021 Apr; 478(7):1377-1397. PubMed ID: 33861845
[TBL] [Abstract][Full Text] [Related]
6. Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes.
Säll J; Pettersson AM; Björk C; Henriksson E; Wasserstrom S; Linder W; Zhou Y; Hansson O; Andersson DP; Ekelund M; Degerman E; Stenkula KG; Laurencikiene J; Göransson O
Diabetologia; 2017 Feb; 60(2):314-323. PubMed ID: 27807598
[TBL] [Abstract][Full Text] [Related]
7. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
[TBL] [Abstract][Full Text] [Related]
8. The CREB coactivator CRTC2 promotes oncogenesis in LKB1-mutant non-small cell lung cancer.
Rodón L; Svensson RU; Wiater E; Chun MGH; Tsai WW; Eichner LJ; Shaw RJ; Montminy M
Sci Adv; 2019 Jul; 5(7):eaaw6455. PubMed ID: 31355336
[TBL] [Abstract][Full Text] [Related]
9. Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration.
Zheng X; Chi J; Zhi J; Zhang H; Yue D; Zhao J; Li D; Li Y; Gao M; Guo J
Oncogene; 2018 Jan; 37(4):502-511. PubMed ID: 28967900
[TBL] [Abstract][Full Text] [Related]
10. Feeding and Fasting Signals Converge on the LKB1-SIK3 Pathway to Regulate Lipid Metabolism in Drosophila.
Choi S; Lim DS; Chung J
PLoS Genet; 2015 May; 11(5):e1005263. PubMed ID: 25996931
[TBL] [Abstract][Full Text] [Related]
11. Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential.
Wein MN; Foretz M; Fisher DE; Xavier RJ; Kronenberg HM
Trends Endocrinol Metab; 2018 Oct; 29(10):723-735. PubMed ID: 30150136
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppression by LKB1: SIK-ness prevents metastasis.
Shaw RJ
Sci Signal; 2009 Sep; 2(86):pe55. PubMed ID: 19724060
[TBL] [Abstract][Full Text] [Related]
13. An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation.
Murray CW; Brady JJ; Tsai MK; Li C; Winters IP; Tang R; Andrejka L; Ma RK; Kunder CA; Chu P; Winslow MM
Cancer Discov; 2019 Nov; 9(11):1590-1605. PubMed ID: 31350327
[TBL] [Abstract][Full Text] [Related]
14. Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes.
Itoh Y; Sanosaka M; Fuchino H; Yahara Y; Kumagai A; Takemoto D; Kagawa M; Doi J; Ohta M; Tsumaki N; Kawahara N; Takemori H
J Biol Chem; 2015 Jul; 290(29):17879-17893. PubMed ID: 26048985
[TBL] [Abstract][Full Text] [Related]
15. Salt-inducible kinases (SIKs) regulate TGFβ-mediated transcriptional and apoptotic responses.
Hutchinson LD; Darling NJ; Nicolaou S; Gori I; Squair DR; Cohen P; Hill CS; Sapkota GP
Cell Death Dis; 2020 Jan; 11(1):49. PubMed ID: 31969556
[TBL] [Abstract][Full Text] [Related]
16. Evidence of cancer-promoting roles for AMPK and related kinases.
Monteverde T; Muthalagu N; Port J; Murphy DJ
FEBS J; 2015 Dec; 282(24):4658-71. PubMed ID: 26426570
[TBL] [Abstract][Full Text] [Related]
17. The multiple roles of salt-inducible kinases in regulating physiology.
Jagannath A; Taylor L; Ru Y; Wakaf Z; Akpobaro K; Vasudevan S; Foster RG
Physiol Rev; 2023 Jul; 103(3):2231-2269. PubMed ID: 36731029
[TBL] [Abstract][Full Text] [Related]
18. LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective.
Ciccarese F; Zulato E; Indraccolo S
Oxid Med Cell Longev; 2019; 2019():8730816. PubMed ID: 31781355
[TBL] [Abstract][Full Text] [Related]
19. Salt-inducible kinases: new players in pulmonary arterial hypertension?
António T; Soares-da-Silva P; Pires NM; Gomes P
Trends Pharmacol Sci; 2022 Oct; 43(10):806-819. PubMed ID: 35851157
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput Implementation of the NanoBRET Target Engagement Intracellular Kinase Assay to Reveal Differential Compound Engagement by SIK2/3 Isoforms.
Jin HY; Tudor Y; Choi K; Shao Z; Sparling BA; McGivern JG; Symons A
SLAS Discov; 2020 Feb; 25(2):215-222. PubMed ID: 31849250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
